ImmunityBio
IBRX
#2494
Rank
C$10.21 B
Marketcap
C$9.60
Share price
7.03%
Change (1 day)
226.90%
Change (1 year)

Earnings for ImmunityBio (IBRX)

Earnings in 2026 (TTM): -C$1.23 Billion

According to ImmunityBio's latest financial reports the company's current earnings are C$0.16 Billion. In 2025 the company made an earning of -C$0.35 Billion, an increase over its 2024 earnings that were of -C$0.42 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for ImmunityBio from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$1.23 Billion257.91%
2025 -C$0.35 Billion-16.85%
2024 -C$0.42 Billion-36.76%
2023 -C$0.66 Billion28.52%
2022 -C$0.51 Billion5.61%
2021 -C$0.49 Billion54.4%
2020 -C$0.32 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-C$0.23 Billion-82.22%๐Ÿ‡บ๐Ÿ‡ธ USA